American International Group
AIG
$80.74
+2.05%
American International Group (AIG) is a global diversified insurance and financial services firm operating through subsidiaries that provide property, casualty, and life insurance, with a primary focus on commercial and institutional clients. Following the spin-off of its life and retirement business, Corebridge Financial, AIG has repositioned itself as a leaner, pure-play general insurance franchise, retaining only a minority stake in Corebridge. The company is widely recognized as a market leader in commercial lines, particularly in the large-account and specialty insurance segments, and is known for its global footprint and underwriting expertise. The current investor narrative centers on management's execution of its underwriting improvement strategy, capital return via buybacks and dividends, and the potential for margin expansion as the portfolio mix shifts toward higher-margin commercial lines. However, the stock has faced headwinds from a soft pricing environment in certain casualty lines and broader market volatility, leaving investors debating whether the current valuation adequately reflects the company's normalized earnings power.…
AIG
American International Group
$80.74
Investment Opinion: Should I buy AIG Today?
Based on the synthesis of analyst consensus, valuation, and fundamental trends, AIG warrants a Hold rating with a slight bullish tilt. The core thesis is that the stock is undervalued on a forward basis (8.76x forward PE) and offers a sustainable dividend yield of 2.02%, but stagnant revenue growth and a soft pricing environment limit near-term upside. The analyst consensus rating of 'Buy' (mean 2.32) and average target price of $88.20 imply 14.5% upside, but the wide target range ($80-$101) reflects uncertainty.
Supporting evidence for the Hold rating includes: 1) Forward PE of 8.76x is well below the industry average of 12-15x, suggesting a value opportunity; 2) Operating margin improved to 19.25% in Q2 2026 from 11.15% in Q3 2025, demonstrating underwriting progress; 3) Free cash flow of $3.85 billion comfortably covers the $263 million quarterly dividend and $645 million in buybacks; 4) Price-to-book of 1.18x is below the industry average of 1.5x, indicating the stock is not expensive relative to book value. However, revenue growth of just 0.62% YoY and a 7.37% decline over the past year highlight the challenges.
The biggest risks that could invalidate the thesis are: 1) A further deterioration in casualty pricing that compresses underwriting margins; 2) A failure to achieve the earnings growth implied by the forward PE, leading to multiple compression; 3) A broader market downturn that disproportionately affects financials. The rating would upgrade to Buy if the forward PE remains below 10x while revenue growth accelerates above 3% and operating margins hold above 18%. It would downgrade to Sell if revenue declines, operating margins fall below 12%, or the stock breaks below the 52-week low of $71.25 on high volume. Relative to its history and peers, AIG appears fairly valued to slightly undervalued, but the lack of growth justifies a cautious stance.
Sign up to view all
AIG 12-Month Price Forecast
AIG presents a mixed picture: the forward valuation is undeniably cheap at 8.76x earnings, and the company has demonstrated meaningful underwriting margin improvement, with operating margin expanding to 19.25% in Q2 2026. However, revenue growth remains anemic at 0.62% year-over-year, and the stock has significantly underperformed the market over the past year. The analyst consensus is moderately bullish, but the wide target range ($80-$101) reflects uncertainty. I would upgrade to bullish if revenue growth accelerates above 3% and operating margins sustain above 18%, or downgrade to bearish if margins fall below 12% or the stock breaks below $71.25. Given the balance of risks and rewards, a neutral stance with a slight value tilt is appropriate.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on American International Group's 12-month outlook, with a consensus price target around $87.70 and implied upside of +8.6% versus the current price.
Average Target
$87.70
0 analysts
Implied Upside
+8.6%
vs. current price
Analyst Count
—
covering this stock
Price Range
$80 - $101
Analyst target range
AIG is covered by 20 analysts, with a consensus recommendation of 'Buy' (recommendation mean of 2.32 on a scale where 1 is Strong Buy and 5 is Strong Sell). The average target price is $88.20, which implies an upside of approximately 14.5% from the current price of $77.04. The consensus is moderately bullish, with the majority of analysts rating the stock as a Buy or Overweight. Recent institutional ratings show a mix of Neutral and Buy ratings, with firms like Argus Research reiterating a Buy, Cantor Fitzgerald maintaining Overweight, and several others (Mizuho, Morgan Stanley, RBC Capital, Wells Fargo, Piper Sandler, Barclays) holding Neutral or Equal Weight ratings. The target price range spans from a low of $80.00 to a high of $101.00, representing a wide spread of 26% from the low to high. The high target of $101.00 implies a 31% upside and likely assumes successful execution of underwriting margin expansion, continued capital return, and a favorable pricing environment. The low target of $80.00 implies a modest 3.8% upside and may reflect concerns about soft pricing, competitive pressures, or a challenging macroeconomic backdrop. The wide target spread indicates high uncertainty among analysts, which is typical for a company undergoing a strategic transformation. The estimated EPS average is $9.51, with a range of $8.26 to $10.15, and estimated revenue average is $32.84 billion. The dispersion in estimates suggests that analysts have varying views on the company's earnings power, but the overall consensus remains positive.
Drowning in data?
Find the real signal!
Bulls vs Bears: AIG Investment Factors
The bull case for AIG rests on its attractive forward valuation (8.76x forward PE), improving underwriting margins (operating margin up to 19.25% in Q2 2026), and strong capital return, while the bear case highlights stagnant revenue growth (0.62% YoY), significant long-term underperformance (-7.37% over 1 year), and soft pricing in casualty lines. Currently, the bear evidence appears slightly stronger due to the persistent revenue stagnation and relative underperformance, but the improving profitability and low valuation provide a compelling counterbalance. The single most important tension is whether AIG can sustain and expand its underwriting margin gains in a soft pricing environment; if margins continue to improve, the stock could re-rate toward its forward PE multiple, but if pricing deteriorates further, earnings could disappoint and the stock may retest its 52-week low of $71.25.
Bullish
- Attractive Forward Valuation: AIG trades at a forward PE of 8.76x, a steep discount to its trailing PE of 15.61x and the diversified insurance industry average of 12-15x. This low multiple suggests the market is pricing in pessimistic earnings expectations, which could reverse if underwriting improvements continue.
- Strong Capital Return Program: In Q2 2026, AIG repurchased $645 million of stock and paid $263 million in dividends, supported by $3.85 billion in trailing free cash flow. The 2.02% dividend yield and sustainable 31.5% payout ratio provide a solid return of capital to shareholders.
- Improving Underwriting Profitability: Operating margin expanded to 19.25% in Q2 2026 from 14.84% in Q1 2026 and 11.15% in Q3 2025, while net margin rose to 13.38% from 11.47% and 8.11% over the same periods. This trend reflects successful portfolio repositioning toward higher-margin commercial lines.
- Low Leverage and Solid Balance Sheet: AIG's debt-to-equity ratio of 0.223 is well below the industry average, and its current ratio of 0.853 is typical for insurers with large investment portfolios. This financial strength supports continued capital return and strategic flexibility.
Bearish
- Stagnant Revenue Growth: Q2 2026 revenue of $7.085 billion grew just 0.62% year-over-year, and the multi-quarter trend shows flat to declining revenue from $7.041 billion in Q2 2025. This lack of top-line expansion limits earnings growth potential and may constrain multiple expansion.
- Significant Long-Term Underperformance: AIG shares have declined 7.37% over the past year, vastly underperforming the S&P 500's 16.0% gain, with a relative strength of -23.37%. The stock is also down 8.58% year-to-date, indicating persistent weakness and negative market sentiment.
- Soft Pricing in Casualty Lines: The company faces a soft pricing environment in certain casualty lines, which could pressure underwriting margins. This is reflected in the wide analyst target range of $80 to $101, indicating uncertainty about future profitability.
- Low Beta Limits Upside Participation: With a beta of 0.528, AIG tends to move only about half as much as the broader market. While this reduces downside volatility, it also means the stock will likely lag in strong bull markets, making it less appealing for growth-oriented investors.
AIG Technical Analysis
AIG's stock is in a recovery phase within a broader range-bound consolidation. Over the past year, the shares have declined 7.37%, underperforming the S&P 500's 16.0% gain, with a relative strength of -23.37%. The current price of $77.04 sits at approximately 36% of the 52-week range of $71.25 to $87.29, indicating that the stock is closer to its lows than highs, which could present a value opportunity or signal persistent weakness. The 1-month price change of +2.68% shows a modest rebound, but the 3-month change of -2.69% and 6-month change of +0.22% suggest choppy, range-bound trading. The 1-month relative strength versus SPY is +0.56%, slightly outperforming the market recently, but the 1-year relative strength of -23.37% highlights significant long-term underperformance. The recent uptick from the September low of $72.78 to $77.04 indicates short-term momentum is improving, but the stock remains below its 52-week high of $87.29, and the 1-month gain is not yet enough to reverse the longer-term downtrend. Key technical support is at the 52-week low of $71.25, while resistance is at the 52-week high of $87.29. A breakdown below $71.25 would signal a continuation of the bearish trend and potentially trigger further selling, while a breakout above $87.29 would confirm a new uptrend and could attract momentum buyers. The stock's beta of 0.528 indicates it is significantly less volatile than the broader market, meaning it tends to move about half as much as SPY; this low beta makes it a defensive holding but also limits upside participation in strong bull markets. The max drawdown of -16.98% over the past year reflects moderate risk, and the short ratio of 2.88 suggests that short sellers are not aggressively positioned against the stock.
Beta
0.53
0.53x market volatility
Max Drawdown
-17.0%
Largest decline past year
52-Week Range
$71-$87
Price range past year
Annual Return
+4.8%
Cumulative gain past year
| Period | AIG Return | S&P 500 |
|---|---|---|
| 1m | +6.1% | +1.2% |
| 3m | +0.3% | +2.7% |
| 6m | +2.6% | +7.5% |
| 1y | +4.8% | +15.5% |
| ytd | -4.2% | +11.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
AIG Fundamental Analysis
AIG's revenue trajectory has been relatively flat, with the most recent quarter (Q2 2026) reporting revenue of $7.085 billion, up just 0.62% year-over-year from $7.041 billion in Q2 2025. Sequentially, revenue increased from $6.65 billion in Q1 2026, but the multi-quarter trend shows stagnation: Q4 2025 revenue was $6.557 billion, Q3 2025 was $6.402 billion, and Q2 2025 was $7.041 billion. The General Insurance segment generated $6.72 billion in the latest quarter, representing the vast majority of revenue, while the Corporate Nonsegment and Reconciling Items contributed $123 million and -$92 million, respectively. The lack of meaningful top-line growth suggests the company is focused on profitability and capital return rather than expansion, which may limit upside but supports stable cash flows. AIG is profitable, with Q2 2026 net income of $948 million and a net margin of 13.38%, up from 11.47% in Q1 2026 and 8.11% in Q3 2025. The gross margin in Q2 2026 was 36.71%, compared to 47.74% in Q1 2026 and 33.76% in Q3 2025, showing some volatility but generally stable levels. Operating margin was 19.25% in Q2 2026, significantly higher than the 14.84% in Q1 2026 and 11.15% in Q3 2025, indicating improving underwriting profitability. The company's ROE of 7.53% and ROA of 1.77% are modest but positive, and the net margin of 11.56% (TTM) is in line with industry averages for diversified insurers. AIG's balance sheet remains solid, with a debt-to-equity ratio of 0.223, well below the industry average, and a current ratio of 0.853, which is slightly below 1 but typical for insurance companies that hold significant investment portfolios. Free cash flow (TTM) is $3.85 billion, and the company generated $1.716 billion in operating cash flow in Q2 2026, up from $155 million in Q1 2026. The company returned capital to shareholders through $645 million in stock repurchases and $263 million in dividends in Q2 2026, demonstrating a commitment to shareholder returns. The dividend yield is 2.02%, and the payout ratio is 31.5%, which is sustainable given the company's cash generation. Overall, AIG's financial health is sound, with low leverage and ample liquidity to fund operations and returns.
Quarterly Revenue
$7.1B
2026-06
Revenue YoY Growth
+0.6%
YoY Comparison
Gross Margin
36.7%
Latest Quarter
Free Cash Flow
$3.9B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is AIG Overvalued?
Since AIG reported positive net income (TTM net income of $948 million in Q2 2026), the PE ratio is the primary valuation metric. The trailing PE is 15.61x, while the forward PE is 8.76x, implying that the market expects significant earnings growth in the coming year. The large gap between trailing and forward PE suggests that analysts anticipate a substantial increase in profitability, likely driven by continued underwriting improvements and capital return. The PEG ratio is -0.04, which is not meaningful due to negative earnings growth in the trailing period, but the forward PE of 8.76x is quite low in absolute terms. Compared to the industry average PE for diversified insurers, which typically ranges from 12x to 15x, AIG's trailing PE of 15.61x is slightly above the midpoint, but the forward PE of 8.76x represents a significant discount. The price-to-book ratio is 1.18x, which is below the industry average of around 1.5x, suggesting the stock is undervalued relative to its book value. The price-to-sales ratio is 1.81x, and the EV/EBITDA is 7.28x, both of which are reasonable for a mature insurance company. Historically, AIG's PE ratio has ranged from as low as 3.0x in 2022 to over 20x in 2025, with the current trailing PE of 15.61x falling in the middle of that range. The forward PE of 8.76x is near the low end of the historical range, indicating that the market is pricing in pessimistic expectations or that the company is poised for a re-rating. The price-to-book ratio of 1.18x is also near the lower end of its historical range (0.72x to 1.25x over the past five years), suggesting that the stock is not expensive relative to its book value. Overall, the valuation appears attractive on a forward basis, but the low forward PE may also reflect concerns about earnings sustainability.
PE
15.6x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 3x~25x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
7.3x
Enterprise Value Multiple
Investment Risk Disclosure
AIG's financial and operational risks are moderate but notable. The company's revenue growth has been virtually flat, with Q2 2026 revenue up only 0.62% year-over-year to $7.085 billion, and the multi-quarter trend shows no meaningful expansion. This stagnation, combined with a gross margin that has fluctuated between 33.76% and 47.74% over recent quarters, indicates potential earnings volatility. Additionally, the current ratio of 0.853 is below 1, which, while typical for insurers, could signal liquidity constraints if investment portfolios underperform. The debt-to-equity ratio of 0.223 is low, but the company's ROE of 7.53% is modest, suggesting that without revenue growth, profitability improvements must come from further margin expansion, which may be challenging in a soft pricing environment.
Market and competitive risks are significant given AIG's exposure to the cyclical commercial insurance market. The stock's beta of 0.528 indicates low correlation with the broader market, but this also means it may not benefit fully from market rallies. The insurance sector is highly competitive, and AIG faces pressure from both traditional rivals and alternative capital providers. The soft pricing environment in casualty lines, as mentioned in the analyst commentary, could compress margins if not offset by underwriting discipline. Furthermore, the wide analyst target range ($80 to $101) reflects uncertainty about the company's strategic execution and the potential for multiple compression if earnings disappoint. With no recent news to provide additional context, the risk of sector rotation away from financials remains a concern.
The worst-case scenario for AIG would involve a combination of deteriorating underwriting margins, a continued soft pricing environment, and a broader market downturn that compresses valuations across the insurance sector. In this scenario, the stock could retest its 52-week low of $71.25, representing a decline of approximately 7.5% from the current price of $77.04. If the bear case fully materializes, with earnings missing estimates and analysts downgrading the stock, the shares could fall to the analyst low target of $80, but that is above the current price, so the more relevant downside is the 52-week low. A more severe scenario, such as a catastrophic loss event or a significant reserve charge, could push the stock below $71.25, potentially to the $65-70 range, implying a 10-15% loss from current levels. The max drawdown over the past year was -16.98%, indicating that a decline of that magnitude is possible in adverse conditions.
FAQ
The key risks for AIG include: 1) Financial risk: Revenue growth is stagnant at 0.62% YoY, and the current ratio of 0.853 is below 1, which could signal liquidity constraints if investment portfolios underperform. 2) Competitive risk: Soft pricing in casualty lines could compress underwriting margins, as evidenced by the wide analyst target range of $80 to $101. 3) Macro risk: With a beta of 0.528, AIG is less volatile than the market, but a recession could reduce demand for commercial insurance and increase claims. 4) Company-specific risk: A large catastrophic loss event could exceed reinsurance coverage and significantly impact earnings. The most severe risk is a combination of margin compression and multiple contraction, which could push the stock to its 52-week low of $71.25, a 7.5% decline from current levels.
Our 12-month forecast for AIG includes three scenarios: Bull case (25% probability) with a target range of $95-$101, driven by successful margin expansion and revenue growth acceleration; Base case (55% probability) with a target range of $85-$90, assuming steady but unspectacular results and continued capital return; Bear case (20% probability) with a target range of $71-$75, triggered by margin compression and a soft pricing environment. The base case is most likely, with the stock gravitating toward the analyst average target of $88.20. The key assumption behind the base case is that operating margins stabilize around 16-17% and revenue grows 1-2%. However, if the company fails to achieve the earnings growth implied by its forward PE, the stock could remain range-bound or decline.
AIG appears undervalued on a forward basis. Its forward PE of 8.76x is significantly below the trailing PE of 15.61x and the industry average of 12-15x, suggesting the market expects substantial earnings growth. The price-to-book ratio of 1.18x is also below the industry average of 1.5x, indicating the stock is not expensive relative to its book value. However, the trailing PE of 15.61x is slightly above the midpoint of the industry range, reflecting trailing earnings that may not fully capture the company's normalized earnings power. The low forward PE implies the market is pricing in either pessimistic earnings expectations or a potential value opportunity. If AIG meets the estimated EPS of $9.51, the stock would be trading at just 8.1x forward earnings, which seems too cheap for a market leader in commercial insurance.
AIG may be a good buy for value-oriented investors seeking a discounted valuation and reliable dividend. The stock trades at a forward PE of 8.76x, well below the industry average of 12-15x, and offers a 2.02% dividend yield with a sustainable 31.5% payout ratio. Analyst consensus is 'Buy' with an average target of $88.20, implying 14.5% upside. However, the company's revenue growth is stagnant at 0.62% YoY, and the stock has underperformed the market by 23.37% over the past year. The biggest downside risk is a retest of the 52-week low of $71.25, representing a 7.5% decline. Therefore, it is a good buy for patient investors with a long-term horizon who can tolerate near-term volatility, but not for those seeking rapid growth.
AIG is more suitable for long-term investment, with a suggested minimum holding period of 2-3 years. The company is in a strategic transformation phase, focusing on underwriting improvements and capital return, which may take time to fully reflect in the stock price. The low beta of 0.528 and dividend yield of 2.02% make it a defensive holding that can provide steady income and lower volatility. Short-term trading is less attractive due to the stock's range-bound trading pattern (3-month change of -2.69%) and lack of near-term catalysts. Long-term investors can benefit from the discounted forward valuation (8.76x PE) and potential multiple expansion as margins improve. However, they must be patient and tolerate periods of underperformance, as the stock has declined 7.37% over the past year.